Real-time enrollment status for this generalized myasthenia gravis (gmg) clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 1:49 PM UTC
| NCT Number | NCT07215949 |
| Recruiting Status | Recruiting |
| Condition | Generalized Myasthenia Gravis (gMG) |
| Phase | PHASE3 |
| Target Enrollment | 15 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Miriam Freimer |
| Last Updated on CT.gov | February 23, 2026 (Feb 23, 2026) |
As of July 19, 2026: Clinical trial NCT07215949 is currently recruiting participants. This phase3 study for generalized myasthenia gravis (gmg) is actively seeking new participants at 1 location across the United States. The study is sponsored by Miriam Freimer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07215949 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07215949 was last updated Feb 23, 2026 (February 23, 2026). HelloStudys verifies this status automatically.